Quinones are widely distributed substances of often potential toxicological significance. On the other hand, cyclic AMP is known to promote a cell-survival response and to retard apoptosis [Berridge, Tan and Hilton (1993) 
INTRODUCTION
Quinones are widely distributed in nature and play essential biological roles. They also occur as substances of potential toxicological significance in environmental pollutants, and some are used as anticancer drugs. Chronic exposure to quinones is mutagenic to cultures of eukaryotic cells and may cause cell death. The cytotoxic effects of quinones have been extensively studied in isolated hepatocytes and in whole liver [1] [2] [3] [4] [5] [6] [7] . Several enzymes are affected by quinones to various degrees [8] . Deleterious results ofprotein-quinone interactions have been exemplified by the toxicity of certain xenobiotic phenolic substances, which can eventually cause allergies, liver damage or cancer. Aberrant metabolism of quinonoid compounds may also have pathological consequences [9] .
Quinones may be toxic to cells by a number of mechanisms including redox cycling, arylation, intercalation, induction of DNA strand breaks, generation of free radicals and interference with mitochondrial respiration [6] . Quinones are mainly involved in the creation of 'oxidative stress' and undergo a stepwise oneelectron reduction to their semiquinone free radical and hydroquinone at the expense of cellular reducing equivalents; this process, known as redox cycling [10, 11] , quickly leads to reactive singlet oxygen and H202 followed by GSH oxidation. Some quinones preferentially redox cycle, in the order menadione > 1,4-naphthoquinone > benzoquinone (BQ), whereas others are preferentially alkylating, acting as thiol agents, in the order 1,4-naphthoquinone > BQ > menadione > 2,3-diOMe-1,4-naphthoquinone [11] . Arylation of nucleophiles is believed to be a more effective mechanism for causing cytotoxicity in isolated hepatocytes than redox cycling alone [11] . Mutagenic and antitumour activities of a number of toxic quinones (e.g. menadione) involve quinone and forskolin restoring the enzyme activity to its basal value. Reduction of BQ with sodium dithionite stoichiometrically prevents the inhibition of adenylate cyclase; in turn, oxidation of hydroquinone with ferricyanide fully restores it, indicating that the oxidized state of the quinone is required for inhibition. In addition, BQ is cytotoxic in vivo on HepG2, a human hepatocellular carcinoma cell line, but the effect can be prevented with forskolin. In plasma membranes, BQ tightly binds only one major and two minor proteins; these BQ-binding proteins were purified by means of labelling with [14C]BQ followed by PAGE under native conditions. Together these observations indicate that the action of quinone can be traced to targeting a limited number of proteins at the plasma membrane in a highly selective way and to affecting key enzymes such as adenylate cyclase. a one-electron reduction to semiquinone radical catalysed by microsomal NADPH-cytochrome P-450 reductase and mitochondrial NADH-ubiquinone oxidoreductase [5, 6, 12] . In addition, BQ-GSH conjugates strongly inhibit glutathione Stransferases, the enzyme family responsible for the detoxification of electrophilic alkylating agents [13] .
The formation of adducts to cellular constituents, mainly thiol-containing proteins, results in their inactivation and causes a marked decrease in intracellular thiols and oxidation ofreduced nicotinamide nucleotides [12] . This process is thought to be responsible for cell killing by BQ and several quinone derivatives without the formation of GSSG. Despite the fact that many enzymes are inhibited by quinones [8] , no specific cellular target has been demonstrated, and the sequence of events that precedes cell death after quinone exposure is still unexplained. BQ is a potent competitive inhibitor for monoamine oxidase A in human brain synaptosomes [14, 15] , an enzyme that regulates the level of catecholamines and indoleamines in the brain. Toxic effects of quinones (e.g. menadione) can also be accounted for by perturbation of intracellular Ca2+ homoeostasis, as quinones have been shown to block protein thiol groups of a Ca2+-ATPase from the endoplasmic or sarcoplasmic reticulum, resulting in an increase in intracellular Ca2+ [16] . More recently, quinone derivatives were proposed as inhibitors of both thromboxane A2 synthase and 5-lipoxygenase [17] .
Previous studies have shown that a variety of redox agents affect adenylate cyclase activity, leading to the assumption that either the enzyme itself is sensitive to redox agents [18] or a transplasma membrane NAD(P)H oxidoreductase acts as a modulating enzyme in these processes [19] [20] [21] [22] [23] . In Preparation of membranes Method 1 Plasma-membrane preparations from bovine brain were prepared by the method of Lopez-Perez et al. [24] and used throughout these studies, unless otherwise specified. Homogenization and membrane purification were carried out at 4 'C. Bovine brains (600 g) were homogenized at 20 % (w/v) in 0.32 M sucrose in a Polytron PT1O/35 (Kinematica G.m.b.H.) at medium speed five times for 1 min, diluted with sucrose to 10 % (w/v) and centrifuged for 10 min at 1000 g. The supernatant was then centrifuged in a CEPA (C. Padberg G.m.b.H., Lahr, Germany) continuous centrifuge at full speed, and the pellet was suspended in 2.5 litres of 25 mM Tris/HCl buffer (pH 7.5) containing 1 mM EDTA for 35 min and centrifuged as above. The pellet was resuspended at about 10-12 mg of protein/ml in 13 % (w/v) sucrose and kept frozen at -80 'C. Portions (3 ml) of thawed pellet preparations were layered on a cushion made of 20 ml of 6 % (w/v) Ficoll in 13 % (w/v) sucrose and centrifuged at 20000 g for 40 min. The membrane suspension concentrated at the Ficoll/sucrose interface was collected, diluted with 2 vol. of 5 mM Tris/HCl (pH 7.6) containing 1 mM EDTA and pelleted at 50000 g for 45 min. The pellet was homogenized in 4 ml of 13 % (w/v) sucrose, and the purification procedure was repeated under the same conditions. The final pellet was resuspended (8-10 mg/ml) in 20 mM Tris/ HCI (pH 7.4) in 300 mM sucrose and stored in liquid N2.
Method 2 As an alternative to the previous method, membranes were also conveniently prepared by the method of Katada et al. [25] with modifications using frozen bovine cortex instead of fresh brains. Bovine brain cortex was frozen in portions in liquid N2 immediately after slaughter and stored at -80°C. Frozen material (5 g) was thawed and homogenized at 10 % (w/v) in a Polytron PTI1O/35 at medium speed five times for 1 min in 25 mM Tris/HCl (pH 8.0) containing 0.32 M sucrose, 1 mM EDTA, 1 mM dithiothreitol (DTT), 3 mM MgCl2 and aprotinin (25 kallikrein inhibiting units/ml). The extract was diluted into the same buffer without sucrose, centrifuged for 5 min at 500 g and the supernatant was centrifuged for 30 min at 17 300 g. The pellet was resuspended in 40 ml of starting buffer without sucrose and MgCl2 and re-centrifuged under the same conditions. The pellet was washed twice in 25 mM Tris/HCl (pH 8.0) containing 1 mM EDTA and aprotinin (100 units/ml). The purified membranes were frozen in liquid N2 and stored at -80 'C.
Membranes from a mouse neuroblastoma cell line mNB41A3 and from a hepatocellular cell line HepG2 were prepared by means of a similar procedure. Cells (30 x 106) were centrifuged at 1000 g for 5 min and resuspended in 25 mM Hepes/Tris buffer (pH 7.4) containing 5 mM MgCl2. The suspension was homogenized in a Polytron PT1200 at medium speed five times for 30 s and re-centrifuged for 5 min at 1000g. The supernatant was centrifuged for 25 min at 17300 g; the pellet was washed once and stored in liquid N2 until used.
Rat liver membranes were prepared immediately after death.
After homogenization in 0.32 M sucrose (10 %, w/v, tissue), the extract was centrifuged for 10 min at 1000 g and the supernatant was centrifuged for 13 min at 25 000 g. The subsequent pellet was resuspended in 25 mM Hepes/Tris buffer (pH 7.4) containing 5 mM MgCl2 and centrifuged under the same conditions. The pellet was suspended into the same buffer at a protein concentration of about 3 mg/ml and used immediately for the assays. Rat brain plasma membranes were prepared essentially as described by Cotman and Matthews [26] .
Assay of adenylate cyclase
Adenylate cyclase activity was determined by the method of Bockaert et al. [27] , and cAMP was purified by the method of Salomon et al. [28] . All measurements were performed in triplicate and gave a standard deviation of less than 3 % for each point. ADP-ribosylation of the membranes by pertussis or cholera toxins was performed as described by Marbach et al. [29] .
Other assays Protein concentration was determined by the method of Bradford [30] . For membrane solubilization, 9 mg of purified plasma membranes was pelleted and solubilized in 2 ml of 0.2 M Tris/HCl buffer (pH 7.4) containing 1 % Lubrol PX, 0.25 M sucrose and 1 mM EDTA; after 10 min incubation at 0 "C, the suspension was centrifuged for 1 h at 150000g.
Non-denaturing gel electrophoresis was performed at 4 "C in [32] . Receptor-binding measurements were performed by the method of Nukina and LaBella [33] , and the data were analysed as described by McPherson et al. [34] using the method of Biirgisser [35] for binding-constant determinations. Cytotoxicity measurements were performed on a human hepatocellular carcinoma cell line, HepG2, grown as described by Augusti-Tacco and Sato [36] [37] ), and it is lower with either 5,8-dihydroxy-1,4-naphthoquinone (naphthazarin, a naphthol derivative with both quinone and diol functionalities), 1,4-or 1,2-naphthoquinone. Finally the 2-substituted quinones, ubiquinone, menadione and adriamycin, are all inactive. In contrast, quinonerelated redox agents such as DCIP also display strong inhibition. Forskolin does not prevent the inhibition; forskolin activation can be balanced in a dose-dependent manner by quinone inhibition, equimolar concentrations of quinone and forskolin restoring the enzyme activity to its basal value.
A decrease in the IC50 value is observed when the membranes benzoquinone and from 500 to 40 ,uM for DCIP on solubilization (Table 2) . Either stronger affinity is induced or new functional groups are made accessible for the quinones. The decoupling of the transduction cascade on solubilization was tested by measuring adenylate cyclase after G-protein activation with GTP[S]. [39, 40] . In addition, dioxygen also reacts with quinones, resulting in oxidative stress. The inhibition of adenylate cyclase under various oxidationreduction states was therefore tested under anaerobic conditions ( Figure 3 and Table 3 ). Reduction of BQ with either sodium (Table 3) . Alkylating agents for thiol groups such as N-ethylmaleimide inactivate the catalytic moiety of adenylate cyclase in a concentration-dependent way [42, 43] (Figure 4) . However, full inhibition of adenylate cyclase cannot be achieved with Nethylmaleimide alone, for even at high concentrations (1 mM) a residual activity of about 2000 still remains. In the presence of low concentrations of BQ (also a thiol-or amine-blocking agent [44, 45] BQ cytotoxicity in vivo on HepG2 cells. BQ is clearly cytotoxic at concentrations used throughout the present studies ( Figure 5 ). Under these conditions less than 22 % remained viable in the presence of 100,uM BQ. Activation of adenylate cyclase with forskolin at high concentration (100,M) partially prevents BQ cytotoxicity, but only in a very limited way, yielding less than 440% viable cells. Forskolin alone, however, is not cytotoxic under similar experimental conditions. The effect of BQ-induced cytotoxicity, and also of its prevention by forskolin, is concentration-dependent ( Figure 5 ).
Membranes from HepG2 hepatocytes were purified and tested for adenylate cyclase activity. The membranes exhibit some, but not very much, activation by forskolin in vitro (with activation to 116 %, 1250% and 1460% compared with basal activity at 1, 10 and 100 ,uM forskolin respectively), in the absence of BQ. Under the same conditions, 25 MM BQ fully inhibited adenylate cyclase in vitro (not shown), despite the fact that, at this concentration of BQ, 62 % of cells still remain viable (see Figure 5 ).
Together these data show that a decrease caused by BQ of the cellular cAMP pool will eventually induce cell death and that forskolin apparently competes with BQ to remove this inhibition, partially restoring the cAMP pool. This, however, does not preclude other mechanisms of quinone cytotoxicity, e.g. only to a very few slowly moving proteins ( Figure 6 ), and has no affinity towards most other detergent-solubilized proteins. Our autoradiograms display only one major and about two minor BQ-binding proteins from plasma-membrane preparations. Thus quinones interact with a very limited number of proteins within the plasma membrane, amongst them adenylate cyclase. BQmediated inhibition is therefore very selective. The choice of experimental conditions, however, is of prime importance to avoid non-specific effects when identifying BQ-binding proteins, as BQ can alkylate a variety of thiols and amines within proteins. Thus SDS/PAGE was shown to be not a useful method, as most membrane proteins would bind BQ non-specifically, because of the stringent conditions used for denaturation (100°C for 5 min) which favour non-specific thiol alkylation.
Conclusion
These studies were performed in order to define the mechanism of quinone-induced inhibition of adenylate cyclase. From our data, the following conclusions can be made. A variety of quinones inhibit adenylate cyclase, BQ, the model compound, being the most effective. To our knowledge, no inhibitor of adenylate cyclase of similar efficiency has been described so far. Alkylating quinones are more effective than redox-cycling quinones. Ambazone acts at much higher concentrations [46, 47] , but menadione, a cytotoxic quinone, has no effect, indicating that the chemical nature of the compound is of importance [48] . Clearly oxidized quinone is required for inhibition, depending on the structural and binding characteristics of the quinone, reduced compounds being unable to produce alkylation. The oxidoreduction state of the quinone in turn could be modulated by the redox potential of the cellular environment, e.g. by means of plasma-membrane oxidoreductases [20] [21] [22] [23] 39, 40] cAMP is known to promote a cell-survival response and to retard apoptosis [49] . The effect of cAMP in maintaining cell viability has been associated with a concentration-dependent inhibition of [3H]thymidine incorporation into DNA and retardation of the intranucleosomal cleavage of DNA that is associated with apoptosis. In these processes, cAMP is believed to act by stimulating the activity of mitochondrial enzymes; however, this pathway has been poorly defined so far. Studies with thymocytes [50, 51] or leukaemic cell lines [52, 53] have shown that cAMP can promote cell death by apoptosis or suppress malignancy by promoting cell differentiation via an isoform of protein kinase [54] [55] [56] and also acts synergistically with steroids to cause apoptosis [57, 58] . Therefore by affecting key enzymes such as adenylate cyclase, quinones would affect the overall cell activity and become cytotoxic to the cell. The quinone concentrations required for maximal inhibition of adenylate cyclase correlate with the toxic doses described in other studies [45] . The site of attack of BQ in adenylate cyclase remains to be established and, owing to the hydrophobic nature of quinones, may involve the cysteines located within the hydrophobic region. Cytotoxic quinones cause the formation of numerous blebs on the plasma membrane [59, 60] , which precede cell death. The stimulus for bleb formation and the final common pathway leading to cell death is still unknown.
Only a very limited number of proteins within the plasma membrane are suitable targets for quinones, amongst them adenylate cyclase. Even proteins that are very sensitive to redox changes in the environment, e.g. the ,l-adrenergic receptor [38] , are not affected by BQ. So the attack is highly selective at this level. This striking observation provides complementary insights into the mechanisms of quinone-mediated cytotoxicity, the plasma membrane being the prime site of action, but other mechanisms of cytotoxic action are not ruled out.
